Cell Cure Ltd.

Stem cell therapy company focused on cures for Parkinson’s and other neurodegenerative diseases.

The company has received $6M over the next 4 years to reach the initial clinical trial stage for Parkinson’s disease. It is located on the Hadassah University Hospital campus’ Biotech Park in Ein Kerem, Jerusalem. It is currently a wholly owned subsidiary of ES Cell International.

Ben Reubinoff, Prof., CSO
Charles S. Irving, PhD, COO

POB 12247
Jerusalem 91121
Israel
Phone: +972-2-677-6190
Fax: +972-2-642-9856

Prof. Reubinoff and his team have developed considerable IP, which is covered by numerous patent applications. The patent applications are owned by ES Cell International. The company is developing human embryonic stem cell-derived cell therapy. When the stem cells are injected into the brain of patients suffering from Parkinson’s disease, the patient will generate dopaminergic neurons. Such dopaminergic therapeutics have been shown to be effective for Parkinson’s disease.